Creyon Bio

Provider of drug design and oligonucleotide-based drug development platform

placeSan Diego, California, United States calendar_todayFounded 2019 groups38 employees language creyonbio.com

Registered entities

Innovation

5 patent families (2 granted) — focus: Physics & computing, Chemistry & metallurgy; filing pace accelerating. Cited 294 times.

YearFilings
20211
20221
20231
20242
20254
20263

Social engagement

Social engagement: 8.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include DCVC, Lux Capital.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

22 Dec 2025
Product launch
Website at Creyon.com
Coming soon